ARCHIVES

Acting Commissioner Tells Grassley He Supports “Academic Freedom” at The Agency, but “At A Proper Time.”

This article is from The Cancer Letter archive.

Vol. 32 No. 43 | December 1, 2006

Download PDF Visit The Full Archive

Related Articles

Study Finds That CTC Was Used Correctly In Medicare Patients

April 26, 2013

UPCI Clarifies Agreement Between Eli Lilly And PCRN.

July 27, 2001

Medenica’s Privileges Extended; Patient sue Hilton Head Physicians

June 4, 1993

DeVita To continue Discussions On Expanded Chops Despite ACCC Coolness; Would Go To DRCCA Board

March 27, 1981

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005

Metastasis Research Is Example Of Progress Under 1971 Cancer Act

May 10, 1991